Continuous Monitoring Outperforms Fingerstick Testing in Patients With T1D, High Glycated Hemoglobin
New evidence supports the use of continuous glucose monitoring as a means to help control glycated hemoglobin levels in people with type 1 diabetes (T1D). The study, which compared continuous ...
A world-first Australian trial shows a simple fingerstick test can accurately detect hepatitis B DNA within an hour ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as ...
A new study confirms finger-stick Hep B tests are as accurate as labs. This 60-minute test can expand global treatment access ...
A clinical trial has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, ...
Adults with uncontrolled type 1 diabetes saw a benefit when using intermittently scanned continuous glucose monitoring (CGM), the randomized FLASH-UK Trial showed. Compared with traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results